Global Animal Stem Cell Therapy Sales Market Insight 2020 by Top Companies, Region, Type and Application

In this report,global Animal Stem Cell Therapy Market will reach 36072 K USD by the end of 2022 with a CAGR of 21.70%

The global Animal Stem Cell Therapy market is valued at 13514 K USD in 2017 and will reach 36072 K USD by the end of 2022, growing at a CAGR of 21.70% during 2017-2022.

Animal stem cell therapy is a usage of animal’s stem cell to treat a disease or disorder. The ability of stem cell is to divide and differentiate into a cell with specialized function useful for repairing body tissues damaged by injury or disease. The animal stem cell therapy process involves three steps which include collection of stem cell sample from animals and preparing the sample to concentrate the stem cells. Finally, the therapy includes transferring the stem cells into the injured site for treatment. Animal stem cell therapy increases the expectancy of life in animals with no side effects. It is available for the treatment of arthritis, degenerative joint disorders, tendon, and ligaments injuries in animals. Stem cell therapy is most often used to treat dogs, cats, and horses. But recent developments made it possible to use animal stem cell therapy in tiger, pig, etc. Present animal stem cell therapy is studied in treatments of the inflammatory bowel, kidney, liver, heart and immune-mediated diseases respectively.

The classification of Animal Stem Cell Therapy includes dogs, horses and others, and the proportion of dogs in 2016 is about 51%, and the proportion is in increasing trend from 2012 to 2016.

Animal Stem Cell Therapy is widely used in veterinary hospitals and research organizations. The most proportion of Animal Stem Cell Therapy is used in veterinary hospitals, and the revenue in 2016 is 8.09 M USD.

XYZ research center data shows that North America is the biggest contributor to the Animal Stem Cell Therapy revenue market, accounted for 55.56% of the total global market with a revenue of 7508 K USD in 2017, followed by Japan, 20.57% with a revenue of 2780 K USD.

VETSTEM BIOPHARMA is the largest company in the global Animal Stem Cell Therapy market, accounted for 22.81% of the revenue market share in 2017, followed by MediVet Biologic and J-ARM, accounted for 17.15% and 14.41% of the revenue market share in 2017. These manufacturers are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Animal Stem Cell Therapy for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

Global Animal Stem Cell Therapy market competition by top manufacturers/players, with Animal Stem Cell Therapy sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
VETSTEM BIOPHARMA
MediVet Biologic
J-ARM
Celavet
Magellan Stem Cells
U.S. Stem Cell
Cells Power Japan
ANIMAL CELL THERAPIES
Animal Care Stem
Cell Therapy Sciences
VetCell Therapeutics
Animacel
Aratana Therapeutics
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Dogs
Horses
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Animal Stem Cell Therapy for each application, including
Veterinary Hospitals
Research Organizations

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Animal Stem Cell Therapy Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Dogs
2.1.2 Horses
2.1.3 Others
2.2 Overall Market Performance(Value)
2.2.1 Dogs
2.2.2 Horses
2.2.3 Others
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Veterinary Hospitals
3.1.2 Research Organizations
4 Manufacturers Profiles/Analysis
4.1 VETSTEM BIOPHARMA
4.1.1 VETSTEM BIOPHARMA Profiles
4.1.2 VETSTEM BIOPHARMA Product Information
4.1.3 VETSTEM BIOPHARMA Animal Stem Cell Therapy Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 VETSTEM BIOPHARMA SWOT Analysis
4.2 MediVet Biologic
4.2.1 MediVet Biologic Profiles
4.2.2 MediVet Biologic Product Information
4.2.3 MediVet Biologic Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.2.4 MediVet Biologic SWOT Analysis
4.3 J-ARM
4.3.1 J-ARM Profiles
4.3.2 J-ARM Product Information
4.3.3 J-ARM Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.3.4 J-ARM SWOT Analysis
4.4 Celavet
4.4.1 Celavet Profiles
4.4.2 Celavet Product Information
4.4.3 Celavet Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Celavet SWOT Analysis
4.5 Magellan Stem Cells
4.5.1 Magellan Stem Cells Profiles
4.5.2 Magellan Stem Cells Product Information
4.5.3 Magellan Stem Cells Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Magellan Stem Cells SWOT Analysis
4.6 U.S. Stem Cell
4.6.1 U.S. Stem Cell Profiles
4.6.2 U.S. Stem Cell Product Information
4.6.3 U.S. Stem Cell Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.6.4 U.S. Stem Cell SWOT Analysis
4.7 Cells Power Japan
4.7.1 Cells Power Japan Profiles
4.7.2 Cells Power Japan Product Information
4.7.3 Cells Power Japan Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.7.4 Cells Power Japan SWOT Analysis
4.8 ANIMAL CELL THERAPIES
4.8.1 ANIMAL CELL THERAPIES Profiles
4.8.2 ANIMAL CELL THERAPIES Product Information
4.8.3 ANIMAL CELL THERAPIES Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.8.4 ANIMAL CELL THERAPIES SWOT Analysis
4.9 Animal Care Stem
4.9.1 Animal Care Stem Profiles
4.9.2 Animal Care Stem Product Information
4.9.3 Animal Care Stem Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Animal Care Stem SWOT Analysis
4.10 Cell Therapy Sciences
4.10.1 Cell Therapy Sciences Profiles
4.10.2 Cell Therapy Sciences Product Information
4.10.3 Cell Therapy Sciences Animal Stem Cell TherapySales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Cell Therapy Sciences SWOT Analysis
4.11 VetCell Therapeutics
4.12 Animacel
4.13 Aratana Therapeutics
5 Market Performance for Manufacturers
5.1 Global Animal Stem Cell Therapy Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Animal Stem Cell Therapy Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Animal Stem Cell Therapy Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Animal Stem Cell Therapy Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Animal Stem Cell Therapy Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Animal Stem Cell Therapy Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Animal Stem Cell Therapy Market Assessment by Regions (2014-2020)
7.1 Global Animal Stem Cell Therapy Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Animal Stem Cell Therapy Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Animal Stem Cell Therapy Price (USD/Unit) by Regions 2014-2020
7.4 Global Animal Stem Cell Therapy Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Animal Stem Cell Therapy Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Veterinary Hospitals Industry
11.2 Research Organizations Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Animal Stem Cell Therapy Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Animal Stem Cell Therapy Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Dogs
12.2.3 Horses
12.2.4 Others
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Veterinary Hospitals
12.3.3 Research Organizations
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Animal Stem Cell Therapy Price (USD/Unit) Trend 2021-2026
12.4.2 Global Animal Stem Cell Therapy Gross Profit Trend 2021-2026
13 Conclusion